The 2026 340B Reckoning: What Manufacturer Rebate Models Mean for Covered Entities
- 0:00 Why 2026 Changes The Math
- 8:00 Policy And Litigation Pressure Points
- 18:00 How Rebate Workflows Function
Practical shifts you can apply this week
-
Identify Operational Changes
Map how rebate models alter purchasing, replenishment, and proof of qualifying use across daily 340B workflows.
-
Evaluate Cash-Flow Risks
Size the effect of payment lag, denials, and financing costs before margin quietly slips out the side door.
-
Compare Rebate Approaches
See where post-sale recovery differs from upfront discounts, and when each model changes the operational burden.
-
Diagnose Control Failures
Spot where claims, data, and contract handoffs are most likely to trigger denials, disputes, or audit trouble.
-
Draft A 2026 Readiness Plan
Leave with a practical plan for governance, finance, pharmacy ops, and manufacturer engagement.
What we'll cover
-
0:00
Why 2026 Changes The Math
Why rebate models shift operational burden, evidence needs, and financial risk onto covered entities.
-
8:00
Policy And Litigation Pressure Points
The disputes, oversight pressure, and visibility demands pushing rebate models into the 340B conversation.
-
18:00
How Rebate Workflows Function
A step-by-step look at purchase, dispense, claim matching, submission windows, denials, and dispute cycles.
-
28:00
Cash Flow And Margin Exposure
How lag time, short-pays, and working capital needs can reshape economics by drug mix and channel.
-
37:00
Compliance Risks In Workflow
Where duplicate discount controls, diversion evidence, and Medicaid flags tend to break under rebate admin.
-
47:00
Covered Entity Strategy Choices
How to weigh vendor dependence, manufacturer concentration, and tolerance for float and denial risk.
-
55:00
90-Day Blueprint And Q&A
Recap the readiness plan, then close with practical next steps and attendee questions.
Questions people ask before registering
-
It is built for working professionals involved in 340B strategy and operations, including pharmacy, finance, compliance, legal, and split-billing teams. If rebate models could touch your purchasing, claims, or audits, this will be relevant.
-
No. We assume professional familiarity with 340B, but we explain the rebate workflow clearly and use concrete examples. You do not need to be a policy lawyer to keep up.
-
Yes. Registered attendees will receive the replay, so you can revisit the workflow diagrams, examples, and readiness steps on your own schedule.
-
Practical. We cover the policy and litigation backdrop, but the focus is operational impact: cash flow, denials, controls, and what to stress-test in the next 90 days.
-
If a certificate of attendance or CE credit is available, the registration page will say so. If it is not listed there, assume the session is educational but not CE-bearing.
-
Bring one product line, one manufacturer relationship, and one contract pharmacy channel you want to stress-test. That makes the closing readiness exercise much more useful.